SCHEMBL8357429

SCHEMBL8357429

O=C(NCc1ccccc1)c1cc(C(=O)NCc2ccc(F)c(Cl)c2)ncn1

nearest known ligand 0.71

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MMP13 P45452 6/20 0.71
MMP10 P09238 1/20 0.53
MMP9 P14780 1/20 0.53
MMP8 P22894 1/20 0.53
PTGER4 P35408 1/20 0.51
HDAC3 O15379 1/20 0.48
HDAC1 Q13547 1/20 0.48
HDAC2 Q92769 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48
EGFR P00533 1/20 0.48
PPARG P37231 3/20 0.47
ALDH1A1 P00352 1/20 0.46
CNR1 P21554 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
ANO1 Q5XXA6 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6479481 0.94 MMP13 (0.71) MMP13MMP10MMP9MMP8PTGER4
SCHEMBL14256100 0.91 MMP13 (0.65) MMP13MMP10MMP9MMP8HDAC3
SCHEMBL14448540 0.91 MMP13 (0.65) MMP13MMP10MMP9MMP8PTGER4
SCHEMBL8357422 0.91 MMP13 (0.61) MMP13MMP10MMP9MMP8HDAC3
SCHEMBL8357432 0.90 MMP13 (0.67) MMP13MMP10MMP9MMP8HDAC3
SCHEMBL8349489 0.89 MMP13 (0.62) MMP13MMP10MMP9MMP8HDAC3
SCHEMBL8348824 0.88 NPC1 (0.58) MMP13PPARGALDH1A1SMN1; SMN2ANO1
SCHEMBL8348424 0.87 MMP13 (0.60) MMP13MMP10MMP9MMP8HDAC3
SCHEMBL8360230 0.87 MEN1 (0.58) MMP13
SCHEMBL8360133 0.86 MMP13 (0.62) MMP13MMP10MMP9MMP8ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1455790-B1 USE OF PYRIDINE-2,4-DICARBOXYLIC ACID DIAMIDES AND OF PYRIMIDINE-4,6-DICARBOXYLIC ACID DIAMIDES FOR SELECTIVE COLLAGENASE INHIBITION SANOFI AVENTIS DEUTSCHLAND (DE) 2008-03-26 EP disclosed
WO-2003049738-A1 USE OF PYRIDINE-2,4-DICARBOXYLIC ACID DIAMIDES AND OF PYRIMIDINE-4,6-DICARBOXYLIC ACID DIAMIDES FOR SELECTIVE COLLAGENASE INHIBITION AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2003-06-19 WO disclosed